Table 2.

Bioengineering strategies to modify characteristics of therapeutic hemostatic proteins

Bioengineering strategies to modify characteristics of therapeutic hemostatic proteins

PSA indicates polysialic acid; FcRn, neonatal Fc receptor; and PTMs, posttranslational modifications.

*Not discussed in text.

View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal